[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SI1603872T1 - Kristaliniäśna sol s-(2-((1-iminoetil)amino)etil)-2-metil-l-cistein maleat hidroklorid - Google Patents

Kristaliniäśna sol s-(2-((1-iminoetil)amino)etil)-2-metil-l-cistein maleat hidroklorid

Info

Publication number
SI1603872T1
SI1603872T1 SI200431696T SI200431696T SI1603872T1 SI 1603872 T1 SI1603872 T1 SI 1603872T1 SI 200431696 T SI200431696 T SI 200431696T SI 200431696 T SI200431696 T SI 200431696T SI 1603872 T1 SI1603872 T1 SI 1603872T1
Authority
SI
Slovenia
Prior art keywords
åethyl
iminoethyl
amino
methyl
crystalline salt
Prior art date
Application number
SI200431696T
Other languages
English (en)
Inventor
Ahmad Sheikh
Lyle R Brostrom
Ann M Czyzewski
Vahid Zia
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of SI1603872T1 publication Critical patent/SI1603872T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
SI200431696T 2003-03-11 2004-03-04 Kristaliniäśna sol s-(2-((1-iminoetil)amino)etil)-2-metil-l-cistein maleat hidroklorid SI1603872T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45349603P 2003-03-11 2003-03-11
EP04717188A EP1603872B1 (en) 2003-03-11 2004-03-04 S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt
PCT/IB2004/000678 WO2004080956A1 (en) 2003-03-11 2004-03-04 S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt

Publications (1)

Publication Number Publication Date
SI1603872T1 true SI1603872T1 (sl) 2011-07-29

Family

ID=32990778

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431696T SI1603872T1 (sl) 2003-03-11 2004-03-04 Kristaliniäśna sol s-(2-((1-iminoetil)amino)etil)-2-metil-l-cistein maleat hidroklorid

Country Status (33)

Country Link
US (2) US20050038120A1 (sl)
EP (1) EP1603872B1 (sl)
JP (1) JP4794433B2 (sl)
KR (2) KR100927911B1 (sl)
CN (1) CN100460387C (sl)
AR (1) AR043521A1 (sl)
AT (1) ATE509909T1 (sl)
AU (1) AU2004220266B2 (sl)
BR (1) BRPI0408226A (sl)
CA (1) CA2518745C (sl)
CL (1) CL2004000472A1 (sl)
CO (1) CO5611122A2 (sl)
CY (1) CY1112461T1 (sl)
DK (1) DK1603872T3 (sl)
ES (1) ES2363001T3 (sl)
GT (1) GT200400040A (sl)
HK (1) HK1088301A1 (sl)
IL (1) IL170554A (sl)
MX (1) MXPA05008674A (sl)
NL (1) NL1025691C2 (sl)
NO (1) NO20054645L (sl)
NZ (1) NZ574218A (sl)
PA (1) PA8597701A1 (sl)
PE (1) PE20050309A1 (sl)
PL (1) PL1603872T3 (sl)
PT (1) PT1603872E (sl)
RU (1) RU2357953C2 (sl)
SG (1) SG155782A1 (sl)
SI (1) SI1603872T1 (sl)
TW (1) TWI352076B (sl)
UY (1) UY28229A1 (sl)
WO (1) WO2004080956A1 (sl)
ZA (1) ZA200506459B (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6094101A (en) * 1999-03-17 2000-07-25 Tropian, Inc. Direct digital frequency synthesis enabling spur elimination
JP4637178B2 (ja) * 2004-09-21 2011-02-23 ヴィヴェス,ホアン イグレシアス 赤外線を用いた粉末材料の造粒及び/又は乾燥方法及び装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE229001T1 (de) * 1994-06-15 2002-12-15 Wellcome Found Zwischenprodukte verwendbar in der herstellung von enzym-inhibitoren
ES2240445T3 (es) * 2000-03-24 2005-10-16 Pharmacia Corporation Compuestos de amidino y sus sales utiles como inhibidores de la oxidonitrico sintasa.
AR031609A1 (es) * 2000-09-15 2003-09-24 Pharmacia Corp Derivados de acido 2-amino-2-alquil-3 heptenoico y heptinoico utiles como inhibidores de oxido nitrico sintetasa
AR031608A1 (es) * 2000-09-15 2003-09-24 Pharmacia Corp Derivados de los acidos 2-amino-2-alquil-3-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa

Also Published As

Publication number Publication date
SG155782A1 (en) 2009-10-29
HK1088301A1 (en) 2006-11-03
US7767850B2 (en) 2010-08-03
NO20054645L (no) 2005-11-25
RU2357953C2 (ru) 2009-06-10
ATE509909T1 (de) 2011-06-15
JP2006519838A (ja) 2006-08-31
ES2363001T3 (es) 2011-07-18
KR100927911B1 (ko) 2009-11-19
CN1787993A (zh) 2006-06-14
NL1025691C2 (nl) 2006-06-30
CY1112461T1 (el) 2015-12-09
AU2004220266B2 (en) 2010-08-19
AR043521A1 (es) 2005-08-03
DK1603872T3 (da) 2011-07-18
WO2004080956A1 (en) 2004-09-23
US20090215891A1 (en) 2009-08-27
ZA200506459B (en) 2006-11-29
US20050038120A1 (en) 2005-02-17
PA8597701A1 (es) 2005-02-04
CL2004000472A1 (es) 2005-05-13
EP1603872A1 (en) 2005-12-14
JP4794433B2 (ja) 2011-10-19
MXPA05008674A (es) 2005-10-18
TWI352076B (en) 2011-11-11
PT1603872E (pt) 2011-06-07
PE20050309A1 (es) 2005-05-04
PL1603872T3 (pl) 2011-09-30
IL170554A (en) 2011-10-31
CN100460387C (zh) 2009-02-11
NL1025691A1 (nl) 2004-09-14
CA2518745C (en) 2010-10-19
BRPI0408226A (pt) 2006-03-01
NO20054645D0 (no) 2005-10-10
KR20090048521A (ko) 2009-05-13
UY28229A1 (es) 2004-11-08
AU2004220266A1 (en) 2004-09-23
EP1603872B1 (en) 2011-05-18
CA2518745A1 (en) 2004-09-23
RU2005125833A (ru) 2006-05-10
NZ574218A (en) 2009-11-27
CO5611122A2 (es) 2006-02-28
GT200400040A (es) 2005-01-14
KR20050107617A (ko) 2005-11-14
TW200508185A (en) 2005-03-01

Similar Documents

Publication Publication Date Title
HUS1900052I1 (hu) 2-acilaminotiazol-származékok vagy sóik
IL175883A0 (en) Herbicidal heteroaroyl-substituted phenylalanine amides
PL1632477T3 (pl) Pochodna benzamidu lub jej sól
HK1086006A1 (en) Diamine derivatives
IL165762A0 (en) Nitrogen-containing aromatic derivatives
GB0324790D0 (en) Amide derivatives
AU2003227360A1 (en) Novel amide derivatives or salts thereof
PL360967A1 (en) Pharmaceutical compound containing donepezyl hydrochloride
EP1652843A4 (en) AMIDE DERIVATIVES
PL377519A1 (pl) Związki N-(indoloetylo-)cykloaminowe
HK1091108A1 (en) Feeding aid
GB0329572D0 (en) Amide derivatives
EP1623972A4 (en) SOLID N-ACYLALANINE OR SALTS THEREOF
PL373794A1 (en) New salts
GB2394468B (en) Rotatable cam element
EP1555457A4 (en) CAM DEVICE
SI1603872T1 (sl) Kristaliniäśna sol s-(2-((1-iminoetil)amino)etil)-2-metil-l-cistein maleat hidroklorid
GB2403474B (en) Amide derivatives
AU2003235889A8 (en) Amide derivatives
EP1538142A4 (en) AMINE DERIVATIVE
TW581261U (en) Polarized fishing eyeglasses
GB0206708D0 (en) Pharmaceutical salts
GB0204683D0 (en) Pharmaceutical salts
GB0319426D0 (en) 3 D cam
AU2003245228A1 (en) Maleate salts